ABN.AS: $40.75 ▲ 0.30 (0.74%)DSFIR.AS: $99.66 ▼ -0.99 (-0.98%)GMAB.CO: $2,487.00 ▲ 42.00 (1.72%)REP.MC: $29.21 ▼ -0.31 (-1.05%)SOON.SW: $267.80 ▲ 3.20 (1.21%)CRWD: $262.80 ▼ -12.24 (-4.45%)HPE: $70.11 ▼ -3.35 (-4.56%)AMD: $590.49 ▼ -17.61 (-2.90%)DELL: $573.94 ▼ -12.13 (-2.07%)PANW: $400.66 ▼ -18.12 (-4.33%)MRNA: $214.38 ▼ -10.62 (-4.72%)AAPL: $339.62 ▲ 2.98 (0.88%)AMZN: $259.81 ▼ -2.62 (-1.00%)MSFT: $540.65 ▲ 5.58 (1.04%)NVDA: $226.49 ▼ -2.79 (-1.22%)CIEN: $404.50 ▼ -45.27 (-10.07%)DDOG: $287.65 ▼ -5.61 (-1.91%)SNPS: $503.45 ▼ -6.54 (-1.28%)CAP.PA: $115.35 ▲ 0.30 (0.26%)TSCO.L: $511.00 ▲ 7.20 (1.43%)WKL.AS: $77.16 ▲ 2.16 (2.88%)

Company Details

Firefly Neuroscience, Inc.

AIFF - NASDAQ

Identifiants & Marche

Ticker AIFF
ISIN US3179701012
CIK 0000803578
Bourse NASDAQ
Devise USD

Classification

Secteur Technology

Entreprise

Pays CA
Siege N/A
Fondee N/A
Site Web Lien

Description

Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.